Head-to-head dispatch
Queen RX vs Sunlight
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).
Marked down on: No LegitScript or PCAB accreditation
Desk Score
A LegitScript-certified compounded GLP-1 telehealth brand with flat, openly published pricing — semaglutide from $88/mo, tirzepatide from $157/mo — plus a separate peptide-therapy program (NAD+, and per the live site, sermorelin) under its own intake.
Marked down on: Injectable only for GLP-1 — no oral tablet route on semaglutide or tirzepatide, despite a generic "Injections and oral options available" line in one landing page's hero that matches nothing else on the site
Sunlight takes this head-to-head with the higher Desk Score, 84/100 (B) against 72/100 (C) for Queen RX. Queen RX still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Queen RX
72/100
C
Sunlight
84/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Queen RX | Sunlight |
|---|---|---|
| Semaglutide | $100/mo (quarterly plan, compounded) | Starts at $88/mo (compounded, injection) |
| Tirzepatide | Not disclosed | Starts at $157/mo (compounded, injection) |
| Coverage | 45 states | All 50 states (varies by provider licensure) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want budget-conscious patients seeking low-cost compounded GLP-1. | Patients who want the lowest published entry price in the ranking and are comfortable with an injection-only compounded program, and don't need an oral or brand-name route. |
| Desk Score | 72/100C | 84/100B |
The verdict
Desk pick — SunlightSunlight takes this head-to-head with the higher Desk Score, 84/100 (B) against 72/100 (C) for Queen RX. Queen RX still holds its ground where its strengths line up with yours.
Choose Queen RX if…
Readers who want budget-conscious patients seeking low-cost compounded GLP-1.
$100/mo (quarterly plan, compounded) sema · Not disclosed tirz · 45 states
Choose Sunlight if…
Patients who want the lowest published entry price in the ranking and are comfortable with an injection-only compounded program, and don't need an oral or brand-name route.
Starts at $88/mo (compounded, injection) sema · Starts at $157/mo (compounded, injection) tirz · All 50 states (varies by provider licensure)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Queen RX · Sunlight.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Queen RX vs CoreAge Rx
- Sunlight vs Vaylen
- Queen RX vs Strut Health
- Sunlight vs Ondra Health
- Queen RX vs Invigor Medical
- Sunlight vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.